Alleles that increase risk for type 2 diabetes mellitus are not associated with increased risk for Alzheimer's disease
Petroula Proitsi(Queen Mary University of London), John Powell(King's College London), Patrizia Mecocci(University of Perugia), Michelle K. Lupton(Queensland University of Technology), Pak C. Sham(University of Hong Kong), Gillian Hunter(University of Edinburgh), Kuang Lin, Rebecca Sims(Amsterdam Neuroscience), Latha Velayudhan(University of Leicester), Bruno Vellas(Centre Hospitalier Universitaire de Toulouse), Julie Williams(UK Dementia Research Institute), Makrina Daniilidou(Aristotle University of Thessaloniki), Bernadette McGuinness(Queen's University Belfast), Iwona Kłoszewska(Medical University of Lodz), Peter Passmore(Queen's University Belfast), Stephen Todd(University of Ulster), David Craig(Translational Genomics Research Institute), Magda Tsolaki(Aristotle University of Thessaloniki), Isabella Fogh(King's College London), Robert Stewart(Heriot-Watt University), Megan Pritchard(King's College London), Hilkka Soininen(University of Eastern Finland), Carol Brayne(Unknown), Simon Lovestone(Royal Buckinghamshire Hospital), Janet Johnston(Queen's University Belfast), Stephen Newhouse(University College London)
Cited by 9
Related Papers
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
|The Lancet|2012|9k
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
|The Lancet|2012|8.4k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Global prevalence of dementia: a Delphi consensus study
|The Lancet|2005|5.3k